HWM
ANAB icon

HighMark Wealth Management’s AnaptysBio ANAB Stock Holding History

HighMark Wealth Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Sell
39,716
-54,334
-58% -$3.29M 0.9% 19
2026
Q1 		$5.22M Hold
94,050
– – 2.12% 10
2025
Q4 		$4.56M Sell
94,050
-41,000
-30% -$1.6M 1.86% 11
2025
Q3 		$4.42M Sell
135,050
-10,500
-7% -$241K 1.95% 10
2025
Q2 		$3.23M Buy
145,550
+53,550
+58% +$1.12M 1.58% 11
2025
Q1 		$1.71M Buy
+92,000
New +$1.53M 1.01% 13

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

HighMark Wealth Management's ANAB Position: Q2 2026 in Review

HighMark Wealth Management reduced its AnaptysBio (ANAB) stake by 58% in Q2 2026, selling an estimated $3.29M and leaving 39,716 shares worth $2.68M. The position accounts for 0.9% of the portfolio, ranked #19.

HighMark Wealth Management first reported a position in ANAB in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.22M in Q1 2026. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • HighMark Wealth Management held 39,716 shares of AnaptysBio worth $2.68M as of Q2 2026.
  • HighMark Wealth Management sold 54,334 AnaptysBio shares in Q2 2026, an estimated $3.29M.
  • AnaptysBio made up 0.9% of HighMark Wealth Management's portfolio in Q2 2026, its #19 holding.
  • HighMark Wealth Management first reported a position in AnaptysBio in Q1 2025 and has held it in 6 quarters since.
  • HighMark Wealth Management's AnaptysBio position peaked at $5.22M in Q1 2026.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.